載入...
Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p/FOXC1 pathway
BACKGROUND: Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibits its antitumor effects are unknown. Here we aimed to identify the effects and...
Na minha lista:
| 發表在: | J Exp Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6884860/ https://ncbi.nlm.nih.gov/pubmed/31783879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1478-3 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|